332 related articles for article (PubMed ID: 10907387)
21. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
[TBL] [Abstract][Full Text] [Related]
22. [Methylphenidate].
Tagaya H; Murayama N; Fukase Y
Nihon Rinsho; 2015 Sep; 73(9):1511-5. PubMed ID: 26394513
[TBL] [Abstract][Full Text] [Related]
23. Attention-deficit-hyperactivity disorder.
Diller LH
N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
[No Abstract] [Full Text] [Related]
24. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder].
Tomás Vila M; Aleu Pérez-Gramunt M; Beseler Soto B; Benac Prefasi M; Pantoja Martínez J; Pitarch Castellano I
An Pediatr (Barc); 2010 Aug; 73(2):78-83. PubMed ID: 20605120
[TBL] [Abstract][Full Text] [Related]
25. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
[TBL] [Abstract][Full Text] [Related]
26. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
27. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.
Goez HR; Scott O; Nevo N; Bennett-Back O; Zelnik N
J Child Neurol; 2012 Dec; 27(12):1547-52. PubMed ID: 22447850
[TBL] [Abstract][Full Text] [Related]
28. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
29. Motor function and methylphenidate effect in children with attention deficit hyperactivity disorder.
Stray LL; Ellertsen B; Stray T
Acta Paediatr; 2010 Aug; 99(8):1199-204. PubMed ID: 20298494
[TBL] [Abstract][Full Text] [Related]
30. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
31. The effect of methylphenidate and placebo on eye-hand coordination functioning and handwriting of children with attention deficit hyperactivity disorder.
Lufi D; Gai E
Neurocase; 2007 Oct; 13(5):334-41. PubMed ID: 18781432
[TBL] [Abstract][Full Text] [Related]
32. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
33. Methylphenidate and the cytochrome P450 system.
Baird R
Can J Psychiatry; 2003 Jul; 48(6):425-6; author reply 426. PubMed ID: 12894619
[No Abstract] [Full Text] [Related]
34. Dexmethylphenidate for attention deficit hyperactivity disorder.
Coury D
Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
[TBL] [Abstract][Full Text] [Related]
35. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
Strawn MN
J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
[No Abstract] [Full Text] [Related]
36. Anti-hyperactivity medication: methylphenidate and amphetamine.
Seeman P; Madras BK
Mol Psychiatry; 1998 Sep; 3(5):386-96. PubMed ID: 9774771
[TBL] [Abstract][Full Text] [Related]
37. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
Solanto MV
Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
[No Abstract] [Full Text] [Related]
38. Classics in Chemical Neuroscience: Methylphenidate.
Wenthur CJ
ACS Chem Neurosci; 2016 Aug; 7(8):1030-40. PubMed ID: 27409720
[TBL] [Abstract][Full Text] [Related]
39. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
40. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
Fone KC; Nutt DJ
Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
